Compounds > isoproterenol

isoproterenol and cantharidin

isoproterenol has been researched along with cantharidin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boknik, P; Knapp, J; Linck, B; Müller, FU; Neumann, J; Schmitz, W; Vahlensieck, U1
Bokník, P; Knapp, J; Linck, B; Lüss, H; Müller, FU; Nacke, P; Neumann, J; Schmitz, W; Vahlensieck, U1
Lasley, RD; Mentzer, RM; Narayan, P1
Bokník, P; Knapp, J; Linck, B; Lüss, H; Müller, FU; Neumann, J; Schmitz, W1
Hofmann, PA; Liu, Q1

Other Studies

5 other study(ies) available for isoproterenol and cantharidin

ArticleYear
Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.
    British journal of pharmacology, 1996, Volume: 119, Issue:3

    Topics: Analysis of Variance; Cantharidin; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Failure; Humans; Isoproterenol; Myocardial Contraction; Myocardium; Phosphorylase Phosphatase; Stimulation, Chemical

1996
The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.
    British journal of pharmacology, 1997, Volume: 120, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Cantharidin; Cattle; Cells, Cultured; Coronary Vessels; Cyclic AMP; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoprotein Phosphatases; Receptors, Adrenergic, beta

1997
Phosphatase inhibitor cantharidin blocks adenosine A(1) receptor anti-adrenergic effect in rat cardiac myocytes.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adrenergic beta-Agonists; Animals; Calcium; Cantharidin; Cyclic AMP; Enzyme Inhibitors; Intracellular Membranes; Isoproterenol; Male; Myocardial Contraction; Myocardium; Phosphoric Monoester Hydrolases; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1

2000
Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes.
    Cardiovascular research, 2001, Volume: 52, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Cantharidin; Cardiotonic Agents; Cell Cycle Proteins; Cells, Cultured; Chick Embryo; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Gene Expression; Heart Failure; Isoproterenol; Luciferases; Myocardium; Phosphoprotein Phosphatases; Phosphorylation; Plant Proteins; Propane; Stimulation, Chemical; Time Factors; Transcription, Genetic

2001
Antiadrenergic effects of adenosine A(1) receptor-mediated protein phosphatase 2a activation in the heart.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:4

    Topics: Adenosine; Adrenergic beta-Agonists; Animals; Calcium-Binding Proteins; Cantharidin; Enzyme Inhibitors; Female; In Vitro Techniques; Isoproterenol; Methylation; Muscle Fibers, Skeletal; Myocardium; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2; Rats; Rats, Wistar; Receptors, Purinergic P1; Troponin I

2002